Royal Bank of Canada’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159K | Buy |
221,829
+215,632
| +3,480% | +$155K | ﹤0.01% | 4972 |
|
|
2025
Q1 | $4K | Sell |
6,197
-5,923
| -49% | -$3.82K | ﹤0.01% | 6045 |
|
|
2024
Q4 | $22K | Buy |
12,120
+3,845
| +46% | +$6.98K | ﹤0.01% | 5583 |
|
|
2024
Q3 | $28K | Buy |
8,275
+576
| +7% | +$1.95K | ﹤0.01% | 5518 |
|
|
2024
Q2 | $23K | Buy |
7,699
+6,278
| +442% | +$18.8K | ﹤0.01% | 5626 |
|
|
2024
Q1 | $8K | Sell |
1,421
-17,408
| -92% | -$98K | ﹤0.01% | 5845 |
|
|
2023
Q4 | $81K | Buy |
18,829
+8,710
| +86% | +$37.5K | ﹤0.01% | 5211 |
|
|
2023
Q3 | $35K | Buy |
10,119
+3,844
| +61% | +$13.3K | ﹤0.01% | 5479 |
|
|
2023
Q2 | $29K | Buy |
6,275
+2,289
| +57% | +$10.6K | ﹤0.01% | 5572 |
|
|
2023
Q1 | $18K | Sell |
3,986
-3,465
| -47% | -$15.6K | ﹤0.01% | 5684 |
|
|
2022
Q4 | $60K | Buy |
7,451
+6,855
| +1,150% | +$55.2K | ﹤0.01% | 5307 |
|
|
2022
Q3 | $3K | Buy |
596
+349
| +141% | +$1.76K | ﹤0.01% | 6430 |
|
|
2022
Q2 | $1K | Sell |
247
-2,886
| -92% | -$11.7K | ﹤0.01% | 6734 |
|
|
2022
Q1 | $26K | Sell |
3,133
-5,787
| -65% | -$48K | ﹤0.01% | 5985 |
|
|
2021
Q4 | $132K | Buy |
8,920
+7,591
| +571% | +$112K | ﹤0.01% | 5204 |
|
|
2021
Q3 | $25K | Buy |
1,329
+895
| +206% | +$16.8K | ﹤0.01% | 6060 |
|
|
2021
Q2 | $8K | Sell |
434
-2,282
| -84% | -$42.1K | ﹤0.01% | 6444 |
|
|
2021
Q1 | $62K | Buy |
2,716
+2,233
| +462% | +$51K | ﹤0.01% | 5271 |
|
|
2020
Q4 | $10K | Buy |
+483
| New | +$10K | ﹤0.01% | 5832 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | – | – | 6344 |
|
|
2020
Q2 | $0 | Sell |
24
-1,135
| -98% | – | ﹤0.01% | 6309 |
|
|
2020
Q1 | $12K | Buy |
1,159
+170
| +17% | +$1.76K | ﹤0.01% | 5270 |
|
|
2019
Q4 | $11K | Buy |
+989
| New | +$11K | ﹤0.01% | 5509 |
|